vmireavizВестник медицинского института «РЕАВИЗ». Реабилитация, Врач и ЗдоровьеBulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)2226-762X2782-1579РЕАВИЗ10.20340/vmi-rvz.2023.5.TX.1vmireaviz-853Research ArticleДонорство и трансплантация органов и тканейOrgan and tissue donation and transplantationРетрансплантация печени в современной концепции лечения её терминальных поражений (обзор литературы)Liver retransplantation in the modern concept of treatment of its terminal pathology (literature review)https://orcid.org/0000-0001-6604-0927АхмедовА. Р.AkhmedovA. R.

Ахмедов Амир Русланович - врач-хирург, научный сотрудник центра трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Amir R. Akhmedov - Surgeon, researcher at the Liver transplantation Center,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

anosova.kate@gmail.comhttps://orcid.org/0000-0002-6362-7914НоврузбековМ. С.NovruzbekovM. S.

Новрузбеков Мурад Сафтарович - д-р мед. наук, профессор, научный руководитель центра трансплантации печени; заведующий кафедрой трансплантологии и искусственных органов, Большая Сухаревская пл., д. 3, Москва, 129090;

профессор кафедры хирургических болезней, ул. Островитянова д. 1, Москва, 117997

Murad S. Novruzbekov - Dr. Sci. (Med.), Professor, Scientific Director of the Liver Transplantation Center; Head of the Department of Transplantology and Artificial Organs, 3 Bolshaya Sukharevskaya Square, Moscow, 129090;

Professor of the Department of Surgical Diseases, 1 Ostrovityanova str., Moscow, 117997

https://orcid.org/0000-0001-8650-0855ГуляевВ. А.GulyaevV. A.

Гуляев Владимир Алексеевич - д-р мед. наук, ведущий научный сотрудник центра трансплантации печени, врач-хирург, 

Большая Сухаревская пл., д. 3, Москва, 129090

Vladimir A. Gulyaev - Dr. Sci. (Med.), leading researcher at the Liver Transplantation Center, surgeon,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0002-0691-5581ОлисовО. Д.OlisovO. D.

Олисов Олег Даниелович - д-р мед. наук, старший научный сотрудник центра трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Oleg D. Olisov - Dr. Sci. (Med.), Senior Researcher at the Liver Transplantation Center,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0003-2305-4055ЛуцыкК. Н.LutsykK. N.

Луцык Константин Николаевич - д-р мед. наук, врач-хирург, заведующий отделением трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Konstantin N. Lutsyk - Dr. Sci. (Med.), Surgeon, Head of the Liver Transplantation Department,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0002-5057-6628МагомедовК. М.MagomedovK. M.

Магомедов Кубай Магомедович - врач-хирург, научный сотрудник центра трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Kubay M. Magomedov - Surgeon, researcher at the liver transplantation center,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0001-5723-4818КазымовБ. И.KazymovB. I.

Казымов Бахтияр Исметович - врач-хирург, научный сотрудник центра трансплантации печени, Большая Сухаревская пл., д. 3, Москва, 129090;

ассистент кафедры хирургических болезней, ул. Краснобогатырская, д. 2, стр. 2, Москва, 107564

 

Bakhtiyar I. Kazymov - Surgeon, researcher at the Liver Transplantation Center, 3 Bolshaya Sukharevskaya Square, Moscow, 129090;

Assistant of the Department of Surgical Diseases, 2 Krasnobogatyrskaya str., p. 2, Moscow, 107564

 

https://orcid.org/0000-0002-2264-7038АлекберовК. Ф.AlekberovK. F.

Алекберов Кямран Файгович - врач-хирург, научный сотрудник центра трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Kyamran F. Alekberov - Surgeon, researcher at the Liver Transplantation Center,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0002-0241-1298АносоваЕ. Ю.AnosovaE. Yu.

Аносова Екатерина Юрьевна - врач-клинический ординатор центра трансплантации печени,

Большая Сухаревская пл., д. 3, Москва, 129090

Ekaterina Yu. Anosova - Clinical resident of the liver transplantation Center,

3 Bolshaya Sukharevskaya Square, Moscow, 129090

https://orcid.org/0000-0001-5889-8675ЯреминБ. И.YareminB. I.

Яремин Борис Иванович - канд. мед. наук, врач-хирург, научный сотрудник центра трансплантации печени, Большая Сухаревская пл., д. 3, Москва, 129090;

доцент кафедры трансплантологии и искусственных органов, ул. Островитянова д. 1, Москва, 117997;

заведующий кафедрой хирургических болезней, ул. Краснобогатырская, д. 2, стр. 2, Москва, 107564

Boris I. Yaremin - Cand. Sci. (Med.), Surgeon, Researcher at the Liver Transplantation Center, 3 Bolshaya Sukharevskaya Square, Moscow, 129090;

Associate Professor of the Department of Transplantology and Artificial Organs, 1 Ostrovityanova str., Moscow, 117997;

Head of the Department of Surgical Diseases, 2 Krasnobogatyrskaya str., p. 2, Moscow, 107564

Научно-исследовательский институт скорой помощи им. Н.В. СклифосовскогоРоссияN.V. Sklifosovsky Research Institute of Emergency MedicineRussian FederationНаучно-исследовательский институт скорой помощи им. Н.В. Склифосовского; Российский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияN.V. Sklifosovsky Research Institute of Emergency Medicine; N.I. Pirogov Russian National Research Medical UniversityRussian FederationНаучно-исследовательский институт скорой помощи им. Н.В. Склифосовского; Московский медицинский университет «Реавиз»РоссияN.V. Sklifosovsky Research Institute of Emergency Medicine; Moscow Medical University "Reaviz"Russian FederationНаучно-исследовательский институт скорой помощи им. Н.В. Склифосовского; Российский национальный исследовательский медицинский университет им. Н.И. Пирогова; Московский медицинский университет «Реавиз»РоссияN.V. Sklifosovsky Research Institute of Emergency Medicine; N.I. Pirogov Russian National Research Medical University; Moscow Medical University "Reaviz"Russian Federation202308102023135153160Copyright © Ахмедов А.Р., Новрузбеков М.С., Гуляев В.А., Олисов О.Д., Луцык К.Н., Магомедов К.М., Казымов Б.И., Алекберов К.Ф., Аносова Е.Ю., Яремин Б.И., 20232023Ахмедов А.Р., Новрузбеков М.С., Гуляев В.А., Олисов О.Д., Луцык К.Н., Магомедов К.М., Казымов Б.И., Алекберов К.Ф., Аносова Е.Ю., Яремин Б.И.Akhmedov A.R., Novruzbekov M.S., Gulyaev V.A., Olisov O.D., Lutsyk K.N., Magomedov K.M., Kazymov B.I., Alekberov K.F., Anosova E.Y., Yaremin B.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestnik.reaviz.ru/jour/article/view/853

Наиболее частыми причинами потери трансплантата печени являются первично нефункциопирующий трансплантат (ПНФТ), тромбоз печёночной артерии (ТПА), рецидивирующие исходные заболевания и хроническое отторжение. Ведущим показанием к ретрансплантации у детей является ТПА. Годичная выживаемость после ретрансплантации составляет примерно 75 %. Снижение затрат на ретрансплантацию органов и экономическая эффективность процедуры остаются спорными вопросами. Математическое моделирование выявило несколько значимых донорских и реципиентских факторов, влияющих на исходы повторной трансплантации. Несмотря на этические и экономические соображения, ретрансплантация является единственным вариантом для пациентов, перенёсших трансплантацию, у которых трансплантаты не прижились. Решение о ретрансплантации должно приниматься с некоторой осмотрительностью, с полным мультидисциплинарным подходом в больших многопрофильных центрах трансплантации.

The work is devoted to the analysis of modern literature data and approaches in performing repeated liver transplantation. The most frequent causes of liver graft loss are PNFT, HAT, recurrent initial disease and chronic rejection. The leading indication for retransplantation in children is HAT. The one-year survival rate after retransplantation is approximately 75%. Reducing the cost of organ retransplantation and the cost-effectiveness of the procedure are controversial issues. Mathematical modeling has identified several significant recipient and donor factors affecting the outcomes of retransplantation. Despite ethical and economic considerations, retransplantation is the only option for transplant patients whose grafts have failed to engraft. The decision to retransplant should be made with some caution, with full multi-type approach in large multidisciplinary transplant centers.

трансплантация печенипервично нефункционирующий трансплантатлист ожиданияретрансплантациярелистингliver transplantationprimary non-functioning graftwaiting listretransplantationrelistingReferencesSRTR Annual Report 2009. Available at: http://www.srtr.org/annual_Reports/default.aspx. Accessed October 22, 2014.1 SRTR Annual Report 2009. Available at: http://www.srtr.org/annual_Reports/default.aspx. Accessed October 22, 2014.Azoulay D, Linhares M, Huguet E, et al. Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg. 2002;236:713-721.2 Azoulay D, Linhares M, Huguet E, et al. Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg. 2002;236:713-721.Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. A single center experience. Ann Surg. 2005 June;241(6):905-918.3 Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. A single center experience. Ann Surg. 2005 June;241(6):905-918.Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed July 13, 2012.4 Organ Procurement and Transplantation Network. http://optn. transplant.hrsa.gov/latestData/rptData.asp. Accessed July 13, 2012.Kashyap R, Jain A, Reyes J, et al. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc. 2001;33:1486-1487.5 Kashyap R, Jain A, Reyes J, et al. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc. 2001;33:1486-1487.Marudanayagam R, Shanmugam V, Sandhu B, et al. Liver retransplantation in adults: a single centre, 25-year experience. HPB. 2010;12(3):217-224.6 Marudanayagam R, Shanmugam V, Sandhu B, et al. Liver retransplantation in adults: a single centre, 25-year experience. HPB. 2010;12(3):217-224.Markmann J, Markowitz J, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg. 1997;226:408-420.7 Markmann J, Markowitz J, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg. 1997;226:408-420.Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):829-838.8 Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):829-838.Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation – a multivariate analysis. Transplantation. 1993 Apr;55(4):807-813.9 Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation – a multivariate anal- ysis. Transplantation. 1993 Apr;55(4):807-813.Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without Adversely Impacting Posttransplant Survival. Ann Surg. 2006 September;244(3):439-450.10 Tector AJ, Mangus RS, Chestovich P, et al. Use of extended crite- ria livers decreases wait time for liver transplantation without Adversely Impacting Posttransplant Survival. Ann Surg. 2006 September;244(3):439-450.Silberhumer GR, Pokorny H, Hetz H, et al. Combination of extended donor criteria and changes in the model for end stage liver disease score predit patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation. 2007;83(5):588-592.11 Silberhumer GR, Pokorny H, Hetz H, et al. Combination of extended donor criteria and changes in the model for end stage liver disease score predit patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation. 2007;83(5):588-592.Amin MG, Wolf MP, TenBrook JA, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004;10(12):1468-1475.12 Amin MG, Wolf MP, TenBrook JA, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004;10(12):1468-1475.Biggins S, Beldecos A, Rabkin J, Rosen H. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transpl. 2002;8:313-322.13 Biggins S, Beldecos A, Rabkin J, Rosen H. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transpl. 2002;8:313-322.Bekker J, Ploem S, De Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9(4):746-757.14 Bekker J, Ploem S, De Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9(4):746-757.Freise CE, Gillespie BW, Koffron AJ, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008 Dec;8(12):2569-2579.15 Freise CE, Gillespie BW, Koffron AJ, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008 Dec;8(12):2569-2579.Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg. 2009 May;208(5):896-903.16 Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg. 2009 May;208(5):896-903.Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr;6(4):783-790.17 Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr;6(4):783-790.Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005 Sep;242(3):314-323.18 Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005 Sep;242(3):314-323.Stevens LH, Emond JC, Piper JB, et al. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992 Feb;53(2):396-399.19 Stevens LH, Emond JC, Piper JB, et al. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992 Feb;53(2):396-399.Shakleton C, Goss J, Swenson K, et al. The impact of micro-surgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia. Am J Surg. 1997;173:431-435.20 Shakleton C, Goss J, Swenson K, et al. The impact of micro- surgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia. Am J Surg. 1997;173:431-435.Stange B, Glanemann M, Nuessler N, et al. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003;9:612-620.21 Stange B, Glanemann M, Nuessler N, et al. Hepatic artery throm- bosis after adult liver transplantation. Liver Transpl. 2003;9:612-620.Ackermann O, Branchereau S, Franchi-Abella S, et al. The long-term outcome of hepatic artery thrombosis after liver transplantation in children: role of urgent revascularization. Am J Transplant. 2012;12(6):1496-1503.22 Ackermann O, Branchereau S, Franchi-Abella S, et al. The long- term outcome of hepatic artery thrombosis after liver transplanta- tion in children: role of urgent revascularization. Am J Transplant. 2012;12(6):1496-1503.Grodzicki M, Anysz-Grodzicka A, Remiszewski P, et al. Treatment of early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2011 Oct;43(8):3039-3042.23 Grodzicki M, Anysz-Grodzicka A, Remiszewski P, et al. Treat- ment of early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2011 Oct;43(8):3039-3042.Reference deleted during page review.24 Reference deleted during page review.Verna EC, Brown Jr RS. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted. Clin Liver Dis. 2008 Aug;12(3):637-659.25 Verna EC, Brown Jr RS. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted. Clin Liver Dis. 2008 Aug;12(3):637-659.Rosen H. Retransplantation for hepatitis C: implications of different policies. Liver Transpl. 2000;6:S41-S46.26 Rosen H. Retransplantation for hepatitis C: implications of different policies. Liver Transpl. 2000;6:S41-S46.Ghobrial R. Retransplantation for recurrent hepatitis C. Liver Transpl. 2002;8:S38-S43.27 Ghobrial R. Retransplantation for recurrent hepatitis C. Liver Transpl. 2002;8:S38-S43.Berenguer M, Prieto M, Palau A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosis. Liver Transpl. 2003;9:228-235.28 Berenguer M, Prieto M, Palau A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosis. Liver Transpl. 2003;9:228-235.Ghobrial R, Farmer D, Baquerizo A, et al. Orthotopic liver transplantation for hepatitis C: outcome, effect of immuno suppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg. 1999;229:824-833.29 Ghobrial R, Farmer D, Baquerizo A, et al. Orthotopic liver trans- plantation for hepatitis C: outcome, effect of immuno suppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg. 1999;229:824-833.Ghobrial R, Colquhoun S, Rosen H, et al. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. Transplant Proc. 1998;30:1740-1741.30 Ghobrial R, Colquhoun S, Rosen H, et al. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immu- nosuppression. Transplant Proc. 1998;30:1740-1741.Rosen H, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation. 1998;66:1612-1616.31 Rosen H, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation. 1998;66:1612-1616.Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364:2405-2416.32 Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364:2405-2416.Fontana RJ, Hughes EA, Appelman H, et al. A case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C following liver retransplantation. Liver Transpl. 2012;18(9):1053-1059.33 Fontana RJ, Hughes EA, Appelman H, et al. A case report of suc- cessful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C following liver retransplantation. Liver Transpl. 2012;18(9):1053-1059.Schiano TD, Charlton M, Younossi Z, et al. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transpl. 2006;12(9):1381-1389.34 Schiano TD, Charlton M, Younossi Z, et al. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transpl. 2006;12(9):1381-1389.Eason JD, Freeman Jr RB, Rohrer RJ, et al. Should liver transplantation be performed for patients with hepatitis B? Transplantation. 1994 Jun 15;57(11):1588-1593.35 Eason JD, Freeman Jr RB, Rohrer RJ, et al. Should liver transplantation be performed for patients with hepatitis B? Transplantation. 1994 Jun 15;57(11):1588-1593.Crespo G, Mariño Z, Navasa M, Forns X. Viral hepatitis in liver transplantation. Gastroenterology. 2012 May;142(6):1373-1383.36 Crespo G, Mariño Z, Navasa M, Forns X. Viral hepatitis in liver transplantation. Gastroenterology. 2012 May;142(6):1373-1383.Viral Hepatitis Surveillance – United States, 2010. Centers for Disease Control and Prevention. http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/Commentary.htm37 Viral Hepatitis Surveillance – United States, 2010. Centers for Disease Control and Prevention. http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/Commentary.htmBrock GN, Mostajabi F, Ferguson N, et al. Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage? Transpl Int. 2011 Jun;24(6):570-581.38 Brock GN, Mostajabi F, Ferguson N, et al. Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage? Transpl Int. 2011 Jun;24(6):570-581.Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl. 2011 Jul;17(7):751-759.39 Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl. 2011 Jul;17(7):751-759.Bravata D, Olkin I, Barnato A, et al. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review. Liver Transpl. 2001;7:191-203.40 Bravata D, Olkin I, Barnato A, et al. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review. Liver Transpl. 2001;7:191-203.Burra P, Mioni D, Cecchetto A, et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol. 2001;34(5): 716-722.41 Burra P, Mioni D, Cecchetto A, et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol. 2001;34(5): 716-722.Pageaux G, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut. 1999;45:421-426.42 Pageaux G, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut. 1999;45:421-426.Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: A study from the ELTR (European Liver Transplant Registry). Am J Transplant. 2010;10(1):138-148.43 Burra P, Senzolo M, Adam R, et al. Liver transplantation for alco- holic liver disease in Europe: A study from the ELTR (European Liver Transplant Registry). Am J Transplant. 2010;10(1):138-148.Montano-Loza AJ, Mason AL, Ma M, et al. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl. 2009;15(10):1254-1261.44 Montano-Loza AJ, Mason AL, Ma M, et al. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl. 2009;15(10):1254-1261.Molmenti EP, Netto GJ, Murray NG, et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl. 2002 Jun;8(6):519-526.45 Molmenti EP, Netto GJ, Murray NG, et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl. 2002 Jun;8(6):519-526.Reich D, Fiel I, Guarrera J, et al. Liver transplantation for auto immune hepatitis. Hepatology. 2000;32:693-700.46 Reich D, Fiel I, Guarrera J, et al. Liver transplantation for auto immune hepatitis. Hepatology. 2000;32:693-700.Trouillot TE, Shrestha R, Kam I, et al. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg. 1999;5:375-380.47 Trouillot TE, Shrestha R, Kam I, et al. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg. 1999;5:375-380.Shaw BW, Gordon RD, Iwatsuki S, et al. Hepatic retransplantation. Transplant Proc. 1985 Feb;17(1):264-271.48 Shaw BW, Gordon RD, Iwatsuki S, et al. Hepatic retransplantation. Transplant Proc. 1985 Feb;17(1):264-271.Maguire D, Hart R, Heaton N, Rela M. A complication of infrarenal arterial conduit following orthotopic liver transplant. HPB (Oxford). 2001;3(4):275-277.49 Maguire D, Hart R, Heaton N, Rela M. A complication of infrarenal arterial conduit following orthotopic liver transplant. HPB (Oxford). 2001;3(4):275-277.Reese PP, Yeh H, Thomasson AM, et al. Transplant center volume and outcomes after liver retransplantation. Am J Transplant. 2009;9(2):309-317.50 Reese PP, Yeh H, Thomasson AM, et al. Transplant center volume and outcomes after liver retransplantation. Am J Transplant. 2009;9(2):309-317.Thuluvath PJ, Guidinger MK, Fung JJ, et al. Liver transplantation in the United States, 1999-2008. Am J Transpl. 2010;10(Part 2): 1003-1019.51 Thuluvath PJ, Guidinger MK, Fung JJ, et al. Liver transplantation in the United States, 1999-2008. Am J Transpl. 2010;10(Part 2): 1003-1019.Akpinar E, Selvaggi G, Levi D, et al. Liver retransplantation of more than two grafts for recurrent failure. Transplantation. 2009; 88(7):884-890.52 Akpinar E, Selvaggi G, Levi D, et al. Liver retransplantation of more than two grafts for recurrent failure. Transplantation. 2009; 88(7):884-890.Ghabril M, Dickson R, Wiesner R. Improving outcomes of liver retransplantation: an analysis of trends and the impact of hepatitis C infection. Am J Transpl. 2008;8:404-411.53 Ghabril M, Dickson R, Wiesner R. Improving outcomes of liver retransplantation: an analysis of trends and the impact of hepatitis C infection. Am J Transpl. 2008;8:404-411.Hong JC, Kaldas FM, Kositamongkol P, et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients. Ann Surg. 2011;254(3):444-449.54 Hong JC, Kaldas FM, Kositamongkol P, et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients. Ann Surg. 2011;254(3):444-449.Marudanayagam R, Shanmugam V, Gunson BK, et al. Liver retransplantation in adults: a single-centre, 25-year experience. HPB. 2010;12:217-224.55 Marudanayagam R, Shanmugam V, Gunson BK, et al. Liver retransplantation in adults: a single-centre, 25-year experience. HPB. 2010;12:217-224.Yao FY, Saab S, Bass NM, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004;39(1):230-238.56 Yao FY, Saab S, Bass NM, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prog- nostic scores. Hepatology. 2004;39(1):230-238.Lerut J, Laterre P, Roggen F, et al. Adult hepatic retransplantation. UCLA experience. Acta Gastroenterol Belg. 1999;62:261-266.57 Lerut J, Laterre P, Roggen F, et al. Adult hepatic retransplanta- tion. UCLA experience. Acta Gastroenterol Belg. 1999;62:261-266.Kumar N, Wall W, Grant D, et al. Liver retransplantation. Transplant Proc. 1999;31:541-542.58 Kumar N, Wall W, Grant D, et al. Liver retransplantation. Transplant Proc. 1999;31:541-542.Meneu Diaz J, Vicente E, Moreno Gonzalez E, et al. Indications for liver retransplantation: 1087 orthotopic liver transplantations between 1986 and 1997. Transplant Proc. 2002;34:306.59 Meneu Diaz J, Vicente E, Moreno Gonzalez E, et al. Indications for liver retransplantation: 1087 orthotopic liver transplantations between 1986 and 1997. Transplant Proc. 2002;34:306.Doyle H, Morelli F, McMichael J, et al. Hepatic retransplantation – an analysis of risk factors associated with outcome. Transplantation. 1996;61:1499-1505.60 Doyle H, Morelli F, McMichael J, et al. Hepatic retransplantation – an analysis of risk factors associated with outcome. Transplantation. 1996;61:1499-1505.Shaw B, Gordon R, Iwatsuki S. Hepatic retransplantation. Transplant Proc. 1985;17:264.61 Shaw B, Gordon R, Iwatsuki S. Hepatic retransplantation. Transplant Proc. 1985;17:264.Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. A singlecenter experience. Ann Surg. 2005 June;241(6):905-918.62 Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. A singlecenter experience. Ann Surg. 2005 June;241(6):905-918.Powelson J, Cosimi A, Lewis W, et al. Hepatic retransplantation in New England – a regional experience and survival model. Transplantation. 1993;55:802-806.63 Powelson J, Cosimi A, Lewis W, et al. Hepatic retransplantation in New England – a regional experience and survival model. Transplantation. 1993;55:802-806.Linhares MM, Azoulay D, Matos D, et al. Liver retransplantation: a model for determining long-term survival. Transplantation. 2006;81(7):1016-1021.64 Linhares MM, Azoulay D, Matos D, et al. Liver retransplantation: a model for determining long-term survival. Transplantation. 2006;81(7):1016-1021.De Carlis L, Slim A, Giacomoni A, et al. Liver retransplantation: indications and results over a 15-year experience. Transplant Proc. 2001;33:1411-1413.65 De Carlis L, Slim A, Giacomoni A, et al. Liver retransplantation: indications and results over a 15-year experience. Transplant Proc. 2001;33:1411-1413.Facciuto M, Heidt D, Guarrera J, et al. Retransplantation for late liver graft failure: Predictors of mortality. Liver Transpl. 2000;6:174-179.66 Facciuto M, Heidt D, Guarrera J, et al. Retransplantation for late liver graft failure: Predictors of mortality. Liver Transpl. 2000;6:174-179.Watt KDS, Lyden ER. McCashland. Poor survival after liver retransplantation: Is hepatitis C to blame? Liver Transpl. 2003; 9(10):1019-1024.67 Watt KDS, Lyden ER. McCashland. Poor survival after liver retransplantation: Is hepatitis C to blame? Liver Transpl. 2003; 9(10):1019-1024.Andes A, Gerstel E, Combescure C, et al. A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis. Transplantation. 2012;93(7):717-722.68 Andes A, Gerstel E, Combescure C, et al. A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis. Transplantation. 2012;93(7):717-722.Pelletier SJ, Schaubel DE, Punch JD, et al. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl. 2005; 11(4):434-440.69 Pelletier SJ, Schaubel DE, Punch JD, et al. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl. 2005; 11(4):434-440.Yoo HY, Maheshwar A, Thuluvath PJ. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl. 2003;9(9):897-904.70 Yoo HY, Maheshwar A, Thuluvath PJ. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl. 2003;9(9):897-904.Perry DK, Willingham DL, Sibulesky L, et al. Should donation after cardiac death liver grafts be used for retransplantation. Ann Hepatol. 2011;10(4):482-485.71 Perry DK, Willingham DL, Sibulesky L, et al. Should donation after cardiac death liver grafts be used for retransplantation. Ann Hepatol. 2011;10(4):482-485.Markmann J, Gornbein J, Markowitz J, et al. A simple model to estimate survival after retransplantation of the liver. Transplantation. 1999;67:422-430.72 Markmann J, Gornbein J, Markowitz J, et al. A simple model to estimate survival after retransplantation of the liver. Transplantation. 1999;67:422-430.Wong T, Devlin J, Rolando N, et al. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation. 1997; 61:878-881.73 Wong T, Devlin J, Rolando N, et al. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation. 1997; 61:878-881.Гранов Д.А., Боровик В.В., Жеребцов Ф.К., Полысалов В.Н., Майстренко Д.Н., Руткин И.О. и др. Ретрансплантация печени: опыт российского научного центра радиологии и хирургических технологий (РНЦРХТ). Вестник трансплантологии и искусственных органов. 2014;13(4):43-47.74 Granov D.A., Borovik V.V., Zherebtsov F.K., Polysalov V.N., Maistrenko D.N., Rutkin I.O. et al. Liver retransplantation: the experience of the Russian Scientific Center of Radiology and Surgical Technologies (RSCRT). Bulletin of Transplantology and Artificial Organs. 2014;13(4):43-47. (In Russ).Хубутия М.Ш., Журавель С.В., Кузнецова Н.К., & Верещагин А.С. Печеночная недостаточность после операций на печени. Анналы хирургической гепатологии. 2014;19(3):27-32.75 Khubutia M.Sh., Zhuravel S.V., Kuznetsova N.K., & Vereshchagin A.S. Liver failure after liver surgery. Annals of Surgical Hepatology. 2014;19(3):27-32. (In Russ).Щерба А.Е., Дзядзько А.М., Минов А.Ф., Катин М.Л., Коротков С.В., Ефимов Д.Ю. и др. Ретрансплантация у пациентов с ишемической холангиопатией трансплантата печени. Вестник трансплантологии и искусственных органов. 2019;21(S):84-84.76 Shcherba A.E., Dziadzko A.M., Aminov A.F., Katin M.L., Korotkov S.V., Efimov D.Yu. et al. Retransplantation in patients with ischemic liver transplant cholangiopathy. Bulletin of Transplantology and Artificial Organs. 2019;21(S):84-84. (In Russ).

The authors declare that there are no conflicts of interest present.